Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.12, 2004-12, pp. : 1593-1614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Amyotrophic Lateral Sclerosis

By Corcia Philippe Meininger Vincent

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1037-1048

Adis International

Access to resources Recommend Favorite

Prospects for the Pharmacotherapy of Amyotrophic Lateral Sclerosis: Old Strategies and New Paradigms for the Third Millennium

By Festoff B.W. Suo Z. Citron B.A.

CNS Drugs, Vol. 17, Iss. 10, 2003-01 ,pp. : 699-717

Adis International

Access to resources Recommend Favorite

Emerging drugs for amyotrophic lateral sclerosis

By Habib Ali Aamer Mitsumoto Hiroshi

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 537-558

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic advances in amyotrophic lateral sclerosis

By Louvel E. Hugon J. Doble A.

Trends in Pharmacological Sciences, Vol. 18, Iss. 6, 1997-06 ,pp. : 196-203

Elsevier

Access to resources Recommend Favorite

Amyotrophic lateral sclerosis, excitotoxicity and riluzole

By Obrenovitch T.P.

Trends in Pharmacological Sciences, Vol. 19, Iss. 1, 1998-01 ,pp. : 9-9

Elsevier

Access to resources Recommend Favorite